Friday, July 18, 2008

Last Day in Budapest

Today marks our last full day of activity in Budapest. It is only fitting that our last company visit was with Albany Molecular Research, Inc. (AMRI). AMRI, headquartered in Albany, NY and founded in 1991, AMRI is the only fully integrated, global contract drug discovery and chemical services provider. AMRI Hungary serves as the Central Eastern European arm for the company's European operations, with their area of expertise in discovery services.
Following a presentation by Business Development Manager Cesare Spadoni, we enjoyed a tour of the laboratory, and also attended presentations on AMRI's IT infrastructure and HR management.

1 comment:

SUNY said...

Our visit to AMRI started with an excellent overview of the highly complex and diverse nature of drug discovery and development. AMRI established its presence in Hungary in 2006 by acquiring Comgenex. By doing so, they have access to Hungary's lower costs and the European market segment. They work with both biotechnology and pharmaceutical companies and their strategy is to be a one-stop shop right from drug discovery to commercial manufacture and sale.
In particular, AMRI's Hungarian operations are involved in the drug development phase using custom library and chemical compound synthesis and high throughput screening of these compounds to generate 'leads' which are further optimized.